Oncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.
Julie Bullock
Advertisement
SVP, Clinical Pharmacology & Translational Medicine
Articles by Julie Bullock
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer
3
Applied Clinical Trials: October 2025 Interactive Digital Edition
4
In With the New
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
